reports
Rhinomed Ltd: 2 directors
Two Directors at Rhinomed Ltd bought/sold 5,400,000 shares at 0.319AUD. The significance rating of the trade was 86/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
DGAP-News: NEW SWAB TAKES AWAY CHILDREN'S FEAR OF SWABBING
DGAP-News: Rhinomed Limited / Key word(s): Miscellaneous NEW SWAB TAKES AWAY CHILDREN'S FEAR OF SWABBING 19.10.2021 / 09:00 The issuer is solely responsible for the content of this announcement. - Rhinoswab JuniorTM is the world's first nasal swab designed specifically to reduce the distress and discomfort children experience during COVID-19 testing - Rhinoswab JuniorTM is a high yield, cost effective swab that can be comfortably self-administered by children - Rhinoswab can be used to sample for COVID-19 and other respiratory diseases, with PCR and rapid antigen tes...
Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.